The FDA has authorized Mayo Clinic to offer mesenchymal stem cells as part of the Regenerative Nephrology Compassionate Use Program. This is an expanded access program.
Explore new insights into neurodegenerative therapies as researchers observe learning mechanisms in the living brain.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback